Diabetes

Top Story

Actos reduces type 2 diabetes risk in adults with prediabetes, prior stroke

Actos reduces type 2 diabetes risk in adults with prediabetes, prior stroke
June 16, 2016

NEW ORLEANS — The risk for developing type 2 diabetes, especially among those with prediabetes and/or who have had strokes may be reduced with the PPAR agonist Actos, according to a presenter here.

“This is the first time any drug has been shown to both prevent diabetes and also to improve [cardiovascular] outcomes — although these two effects are not necessarily linked,” Silvio E. Inzucchi, MD, director of the Yale Diabetes Center, told Endocrine Today.

FDA News

FDA strengthens kidney warnings on Invokana, Farxiga labels

June 14, 2016
The FDA issued a drug safety communication stating that it has revised the warning labels of SGLT2 inhibitors Invokana/Invokamet and Farxiga/Xigduo XR to include…
Meeting News Coverage

Jardiance slows kidney disease progression in adults with type 2 diabetes

June 14, 2016
NEW ORLEANS — The SGLT2 inhibitor Jardiance was associated with slower progression of kidney disease and fewer clinically relevant renal events compared with…
Meeting News Coverage

Diabetes Collaborative Registry highlights real-world clinical management of patients with diabetes

June 14, 2016
NEW ORLEANS — Clinicians who submit data to the Diabetes Collaborative Registry regularly adhere to four of seven quality metrics when treating patients with…
CME

The Patient With Atrial Fibrillation

No commercial support for this activity.

Atrial fibrillation is the most common type of tachyarrhythmia and is characterized by disorganization of the heart’s…
More »
Video
Meeting News Coverage

VIDEO: Breaks in sitting time reduce cardiometabolic risk factors in type 2 diabetes

May 4, 2016
More »
Featured
Highlights from ACC Scientific Session

Highlights from ACC Scientific Session

Video
Meeting News Coverage

VIDEO: Extended-release aspirin provides stable antiplatelet effect

November 14, 2015
More »
In the Journals

Type 2 diabetes, prior CVD raise risk for CKD

June 9, 2016
Adults with long-standing type 2 diabetes and prior cardiovascular disease are more likely to have chronic kidney disease vs. patients without those…

In the Journals

Large initial weight loss mitigates CVD risk

June 9, 2016
A large initial weight loss can improve some risk factors for cardiovascular disease even if weight is regained, according to study findings…

Pharmacology Consult

New pharmacological therapies change management strategy for hyperkalemia

Cardiology Today, June 2016
TuTran Nguyen, PharmD, BCPS
Chronic kidney disease, defined as the presence of albuminuria or estimated glomerular filtration rate of less than 90 mL/min/1.73 m2, impairs the…

Meeting News Coverage

Two analyses show patiromer may benefit patients with HF

June 6, 2016
Two analyses presented at the 53rd European Renal Association – European Dialysis and Transplant Association Congress showed favorable…

Meeting News Coverage

ATMOSPHERE: Aliskiren fails to benefit patients with HF, diabetes vs. enalapril

May 26, 2016
In patients with diabetes and HF, the direct renin inhibitor aliskiren did not significantly improve outcomes compared with the ACE inhibitor…

Meeting News Coverage

Insulin resistance a culprit for non-alcoholic fatty liver disease

May 21, 2016
NEW ORLEANS — The prevalence of nonalcoholic fatty liver disease is high in patients with diabetes, and insulin resistance is a common cause…

Meeting News Coverage

Despite guideline changes, statin use unchanged or lower in patients with diabetes

May 21, 2016
NEW ORLEANS — The rate of statin use in adults with diabetes has remained steady or declined since 2014, according to findings presented at the…

Trial Scorecards

Trial Scorecard: STAMPEDE

Cardiology Today, May 2016
Researchers compared outcomes of intensive medical therapy, Roux-en-Y gastric bypass surgery or sleeve gastrectomy in patients with mild to moderate…

Meeting News CoverageVideo

VIDEO: Breaks in sitting time reduce cardiometabolic risk factors in type 2 diabetes

May 4, 2016
ORLANDO, Fla. — Bronwyn Kingwell, PhD, head of metabolic and vascular physiology at Baker IDI Heart and Diabetes Institute, Melbourne…

Meeting News Coverage

Femoropopliteal DCB effective in women, patients with diabetes, CTO

May 4, 2016
A drug-coated balloon was effective in women, in patients with diabetes and in those with chronic total occlusions, according to new data. Analyses…

More Headlines »
morganatic-roan